Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Mitogen-activated protein kinase 14 | ||
Ligand | BDBM50352571 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_767362 (CHEMBL1825474) | ||
IC50 | 1.4±n/a nM | ||
Citation | Eastwood, P; González, J; Gómez, E; Caturla, F; Balagué, C; Orellana, A; Domínguez, M Indolin-2-one p38a inhibitors II: Lead optimisation. Bioorg Med Chem Lett21:5270-3 (2011) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Mitogen-activated protein kinase 14 | |||
Name: | Mitogen-activated protein kinase 14 | ||
Synonyms: | CSAID-binding protein | CSBP | CSBP1 | CSBP2 | CSPB1 | Cytokine suppressive anti-inflammatory drug-binding protein | MAP kinase 14 | MAP kinase MXI2 | MAP kinase p38 alpha | MAPK 14 | MAPK14 | MAX-interacting protein 2 | MK14_HUMAN | MXI2 | Mitogen-activated protein kinase p38 alpha | SAPK2A | Stress-activated protein kinase 2a | p38 MAP kinase alpha/beta | ||
Type: | Serine/threonine-protein kinase | ||
Mol. Mass.: | 41286.76 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q16539 | ||
Residue: | 360 | ||
Sequence: |
| ||
BDBM50352571 | |||
n/a | |||
Name | BDBM50352571 | ||
Synonyms: | CHEMBL1825152 | ||
Type | Small organic molecule | ||
Emp. Form. | C24H26N2O3 | ||
Mol. Mass. | 390.4748 | ||
SMILES | Cc1ccc(cc1-c1ccc2c(NC(=O)[C@]22CC[C@H](O)CC2)c1)C(=O)NC1CC1 |r,wU:18.20,wD:15.15,(14.49,-15.14,;15.83,-15.9,;17.16,-15.12,;18.5,-15.89,;18.51,-17.43,;17.18,-18.2,;15.84,-17.44,;14.51,-18.21,;14.52,-19.76,;13.18,-20.53,;11.85,-19.76,;11.85,-18.22,;10.39,-17.74,;9.48,-18.99,;7.94,-18.98,;10.38,-20.23,;8.89,-20.63,;8.49,-22.11,;9.58,-23.21,;9.17,-24.69,;11.07,-22.81,;11.48,-21.32,;13.18,-17.44,;19.84,-18.2,;19.85,-19.74,;21.17,-17.42,;22.51,-18.19,;23.29,-19.52,;24.05,-18.18,)| | ||
Structure |